Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Obseva Sa Ordinary Shares (OBSV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018

ObsEva SA / ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 11.97 (-4.39%)
ObsEva SA (OBSV) Reports Q2 Loss, Misses Revenue Estimates

ObsEva SA (OBSV) delivered earnings and revenue surprises of 9.26% and -100.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

OBSV : 11.97 (-4.39%)
ObsEva SA to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / ObsEva SA (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 8:00 AM Eastern Time.

OBSV : 11.97 (-4.39%)
ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update

ObsEva SA / ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 11.97 (-4.39%)
ObsEva SA (OBSV) Sees Hammer Chart Pattern: Time to Buy?

ObsEva has been struggling lately, but the selling pressure may be coming to an end soon.

OBSV : 11.97 (-4.39%)
ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018

ObsEva SA / ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 11.97 (-4.39%)
ObsEva Expands Executive Team Hiring a Chief Commercial Officer

ObsEva SA / ObsEva Expands Executive Team Hiring a Chief Commercial Officer . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement....

OBSV : 11.97 (-4.39%)
ObsEva SA Shares to Begin Trading on SIX Swiss Exchange

ObsEva SA / ObsEva SA Shares to Begin Trading on SIX Swiss Exchange . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

OBSV : 11.97 (-4.39%)
ObsEva Announces Pricing of Follow-on Public Offering

ObsEva SA / ObsEva Announces Pricing of Follow-on Public Offering . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

OBSV : 11.97 (-4.39%)
ObsEva Announces Launch of Proposed Follow-on Public Offering

ObsEva SA / ObsEva Announces Launch of Proposed Follow-on Public Offering . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement....

OBSV : 11.97 (-4.39%)
ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis

ObsEva SA / ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis . Processed and transmitted by Nasdaq Corporate...

OBSV : 11.97 (-4.39%)
ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018

ObsEva SA / ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18,...

OBSV : 11.97 (-4.39%)
New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Novo Nordisk A/S, HudBay Minerals, Tecnoglass, and Endeavour Silver -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ObsEva SA (NASDAQ:OBSV), Gran...

OBSV : 11.97 (-4.39%)
HBM : 4.65 (+1.09%)
NVO : 47.46 (-0.65%)
GTE : 3.10 (unch)
EXK : 2.20 (+5.26%)
TGLS : 9.42 (-3.29%)
ObsEva SA to Seek SIX Share Listing

ObsEva SA / ObsEva SA to Seek SIX Share Listing . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

OBSV : 11.97 (-4.39%)
ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018

ObsEva SA / ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 11.97 (-4.39%)
ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018

ObsEva SA / ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 11.97 (-4.39%)
ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)

ObsEva SA / ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109) . Processed...

OBSV : 11.97 (-4.39%)
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City

ObsEva SA / ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...

OBSV : 11.97 (-4.39%)
Analysis: Positioning to Benefit within Fortress Transportation and Infrastructure Investors, Turquoise Hill Resources, FactSet Research, Shaw Communications, El Pollo Loco, and ObsEva SA -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fortress Transportation and...

TRQ : 2.35 (+2.62%)
OBSV : 11.97 (-4.39%)
FDS : 220.53 (+1.05%)
FTAI : 18.36 (-0.54%)
SJR : 20.82 (+1.51%)
LOCO : 12.50 (+2.04%)
ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018

ObsEva SA / ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 11.97 (-4.39%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC +1.23 , FTNT -0.09 , CAKE +0.97 , PLT +0.52 , AEO +0.88
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed the day with fractional to 1 cent losses in most nearby contracts, as September was up 1.82% on the week. CFTC data on Friday showed spec traders trimming their net short position in corn futures and options by 4,743 contracts dur...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar